These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6446394)

  • 21. [Clinical study on sulbactam/cefoperazone in urinary tract infections in elderly patients].
    Oyabu Y
    Jpn J Antibiot; 1996 Mar; 49(3):250-5. PubMed ID: 8935120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Worldwide clinical experience with cefoperazone.
    Gerber AU; Craig WA
    Drugs; 1981; 22 Suppl 1():108-18. PubMed ID: 6456884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cefminox versus cefotaxime in the treatment of complicated urinary tract infection].
    Gastón de Iriarte E; Cárcamo Valor P; Diez-Enciso M; Prieto Prieto J; Pérez Balcabao I; Gimeno del Sol M; Coronel Granado P; Morán Soto MJ
    Actas Urol Esp; 1995 Sep; 19(8):635-41. PubMed ID: 8669331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies of efficacy of piperacillin against complicated urinary tract infections].
    Ikeuchi T; Yogi S; Ueno M; Morikawa F; Onodera Y; Sakamoto M; Kai Y
    Hinyokika Kiyo; 1986 Jan; 32(1):143-50. PubMed ID: 3962805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Five-day therapy with cephradine capsules, 500 mg BID, for the treatment of acute, uncomplicated urinary tract infections.
    Brosof AB
    Clin Ther; 1980; 3(4):285-91. PubMed ID: 7023676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefoperazone therapy of serious infections.
    Temple J; Mogabgab WJ
    Clin Ther; 1982; 4(6):450-64. PubMed ID: 6212120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefoperazone in the treatment of postsurgical wound infection, sepsis, and abscess of the spinal cord and brain.
    Woo JH; Ryu JK
    Clin Ther; 1984; 6(6):839-43. PubMed ID: 6509463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [1st personal experiences with carbenicillin therapy of urinary tract infections due to Pseudomonas aeruginosa].
    De Rosa F
    G Mal Infett Parassit; 1971 Nov; 23(11):1068-70. PubMed ID: 5004854
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical trials of carbenicillin therapy in infections due to Pseudomonas aeruginosa].
    Malfatti S; Pardini C; Silvi G
    G Mal Infett Parassit; 1971 Nov; 23(11):1063-8. PubMed ID: 5004853
    [No Abstract]   [Full Text] [Related]  

  • 32. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
    Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
    Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter clinical study of cefoperazone.
    Alix M; Arreza V; Brillantes S; Estrellado R; Gempesaw C; Monteron R; Pascasio F; Pena A; Claudio-Saniel M
    Clin Ther; 1984; 6(3):344-53. PubMed ID: 6722861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newer carbapenems for urinary tract infections.
    Matsumoto T; Muratani T
    Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S35-8. PubMed ID: 15364304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy of piperacillin versus carbenicillin for complicated urinary tract infections.
    Sharifi R; Lee M; Ojeda L
    Urol Int; 1984; 39(6):345-51. PubMed ID: 6395464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multicenter research on cefoperazone efficacy and tolerance in the therapy of urinary and respiratory infections].
    Paradisi F; de Crescenzo G; Ruffilli MP
    Minerva Med; 1989 Jan; 80(1):43-51. PubMed ID: 2644585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
    Gesser RM; McCarroll K; Teppler H; Woods GL
    J Antimicrob Chemother; 2003 May; 51(5):1253-60. PubMed ID: 12697633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of cefovecin (Convenia) for the treatment of urinary tract infections in dogs.
    Passmore CA; Sherington J; Stegemann MR
    J Small Anim Pract; 2007 Mar; 48(3):139-44. PubMed ID: 17355604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.